Artiva Biotherapeutics presents at Stifel forum as NK cell therapy gains traction
UKPulse Markets Desk
Artiva Biotherapeutics appeared at the Stifel forum, where its NK cell therapy was described as gaining traction.
- Artiva Biotherapeutics presented at the Stifel forum.
- The company's NK cell therapy was reported to be gaining traction.
Artiva Biotherapeutics presented at the Stifel forum, according to a report from Investing.com UK dated 24 September 2026.
The report stated that the company's NK cell therapy is gaining traction. No further details of the presentation, the therapy or its development stage were provided in the available source material.